TY - JOUR
T1 - Varicella vaccination in Japan, South Korea, and Europe
AU - Sadzot-Delvaux, Catherine
AU - Rentier, Bernard
AU - Wutzler, Peter
AU - Asano, Yoshizo
AU - Suga, Sadao
AU - Yoshikawa, Tetsushi
AU - Plotkin, Stanley A.
N1 - Funding Information:
pacity for funding national vaccination programs is limited (table 2). Thus, UV is in fact recommended in Lithuania, but it cannot be incorporated into the national childhood immunization schedule because the vaccine is not funded by the state. Consequently, the vaccine is rarely administered.
PY - 2008/3/1
Y1 - 2008/3/1
N2 - The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.
AB - The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.
UR - http://www.scopus.com/inward/record.url?scp=42549157579&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42549157579&partnerID=8YFLogxK
U2 - 10.1086/522163
DO - 10.1086/522163
M3 - Article
C2 - 18419395
AN - SCOPUS:42549157579
VL - 197
SP - S185-S190
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
SN - 0022-1899
IS - SUPPL. 2
ER -